Abstract
Genome-wide association studies (GWAS) have identified several common genetic variants influencing major depression and general cognitive abilities, but little is known about whether the two share any of their genetic aetiology. Here we investigate shared genomic architectures between major depression (MD) and general intelligence (INT) with the MiXeR statistical tool and their overlapping susceptibility loci with conjunctional false discovery rate (conjFDR), which evaluate the level of overlap in genetic variants and improve the power for gene discovery between two phenotypes. We analysed GWAS data on MD (n = 480,359) and INT (n = 269,867) to characterize polygenic architecture and identify genetic loci shared between these phenotypes. Despite non-significant genetic correlation (rg = −0.0148, P = 0.50), we observed large polygenic overlap and identified 92 loci shared between MD and INT at conjFDR < 0.05. Among the shared loci, 69 and 64 are new for MD and INT, respectively. Our study demonstrates polygenic overlap between these phenotypes with a balanced mixture of effect.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Bidirectional genetic overlap between bipolar disorder and intelligence
BMC Medicine Open Access 30 November 2022
-
Polygenic risk and causal inference of psychiatric comorbidity in inflammatory bowel disease among patients with European ancestry
Journal of Translational Medicine Open Access 27 January 2022
-
Characterising the shared genetic determinants of bipolar disorder, schizophrenia and risk-taking
Translational Psychiatry Open Access 08 September 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





Data availability
Data used in this article were obtained from the UK Biobank (https://www.ukbiobank.ac.uk/), the Psychiatric Genomics Consortium (https://www.med.unc.edu/pgc/) and 23andMe (https://www.23andme.com/).
Code availability
The codes for MiXeR and conditional and conjunctional FDR analyses are publicly available at https://github.com/precimed/mixer and https://github.com/precimed/pleiofdr/, respectively.
References
Kupfer, D. J., Frank, E. & Phillips, M. L. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 379, 1045–1055 (2012).
Ferrari, A. J. et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 10, e1001547 (2013).
Gustavsson, A. et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21, 718–779 (2011).
Kessler, R. C. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095–3105 (2003).
Vancampfort, D. et al. Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol. Med. 44, 2017–2028 (2014).
Geschwind, D. H. & Flint, J. Genetics and genomics of psychiatric disease. Science 349, 1489–1494 (2015).
Pan, Z. et al. Cognitive impairment in major depressive disorder. CNS Spectr. 24, 22–29 (2019).
Szmulewicz, A. G. et al. Neuropsychological profiles of major depressive disorder and bipolar disorder during euthymia. A systematic literature review of comparative studies. Psychiatry Res. 248, 127–133 (2017).
Beck, A. T. The evolution of the cognitive model of depression and its neurobiological correlates. Am. J. Psychiatry 165, 969–977 (2008).
Otte, C. et al. Major depressive disorder. Nat. Rev. Dis. Primers 2, 16065 (2016).
Navrady, L. B. et al. Intelligence and neuroticism in relation to depression and psychological distress: evidence from two large population cohorts. Eur. Psychiatry 43, 58–65 (2017).
Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984–994 (2013).
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
Hyde, C. L. et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat. Genet. 48, 1031–1036 (2016).
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
Savage, J. E. et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat. Genet. 50, 912–919 (2018).
Davies, G. et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat. Commun. 9, 2098 (2018).
Glazier, A. M., Nadeau, J. H. & Aitman, T. J. Finding genes that underlie complex traits. Science 298, 2345–2349 (2002).
Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177–1186 (2017).
Frei, O. et al. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nat. Commun. 10, 2417 (2019).
Efron, B. Large-Scale Inference: Empirical Bayes Methods for Estimation, Testing, and Prediction Vol. 1 (Cambridge Univ. Press, 2010).
Andreassen, O. A., Thompson, W. K. & Dale, A. M. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophr. Bull. 40, 13–17 (2014).
Smeland, O. B. et al. Discovery of shared genomic loci using the conditional false discovery rate approach. Hum. Genet. 139, 85–94 (2019).
Wang, Y. et al. Leveraging genomic annotations and pleiotropic enrichment for improved replication rates in schizophrenia GWAS. PLoS Genet. 12, e1005803 (2016).
Smeland, O. B. et al. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder and general cognitive ability. Mol. Psychiatry 25, 844–853 (2018).
Andreassen, O. A. et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum. Genet 92, 197–209 (2013).
Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315 (2014).
Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790–1797 (2012).
GTEx Consortium. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 18, 497–511 (2013).
Smeland, O. B. et al. Identification of genetic loci jointly influencing schizophrenia risk and the cognitive traits of verbal-numerical reasoning, reaction time, and general cognitive function. JAMA Psychiatry 74, 1065–1075 (2017).
Barch, D. M. Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences. Curr. Psychiatry Rep. 11, 313–319 (2009).
Hill, W. D., Harris, S. E. & Deary, I. J. What genome-wide association studies reveal about the association between intelligence and mental health. Curr. Opin. Psychol. 27, 25–30 (2018).
Taylor, C. L. Creativity and mood disorder: a systematic review and meta-analysis. Perspect. Psychol. Sci. 12, 1040–1076 (2017).
Ramasamy, A. et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17, 1418–1428 (2014).
Fregeau, B. et al. De novo mutations of RERE cause a genetic syndrome with features that overlap those associated with proximal 1p36 deletions. Am. J. Hum. Genet. 98, 963–970 (2016).
Hidese, S. et al. Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 76, 12–18 (2017).
Deary, I. J., Penke, L. & Johnson, W. The neuroscience of human intelligence differences. Nat. Rev. Neurosci. 11, 201–211 (2010).
Bannerman, D. M. et al. Somatic accumulation of GluA1-AMPA receptors leads to selective cognitive impairments in mice. Front. Mol. Neurosci. 11, 199 (2018).
Armstrong, D. D., Deguchi, K. & Antallfy, B. Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain. J. Child Neurol. 18, 683–687 (2003).
Hara, Y., Waters, E. M., McEwen, B. S. & Morrison, J. H. Estrogen effects on cognitive and synaptic health over the lifecourse. Physiol. Rev. 95, 785–807 (2015).
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).
Kamburov, A., Stelzl, U., Lehrach, H. & Herwig, R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res. 41, D793–D800 (2013).
Acknowledgements
We would like to thank the research participants and the Major Depression Working Group of the Psychiatric Genomics Consortium, 23andMe and Intelligence cohorts for making their GWAS summary statistics available. We gratefully acknowledge support from the American National Institutes of Health (NS057198, EB00790), the European Union’s Horizon2020 Research and Innovation Action Grant No. 847776 CoMorMent, the Research Council of Norway (229129, 213837, 248778, 273291, 223273), the South-East Norway Regional Health Authority (2017-112) and K.G. Jebsen Stiftelsen (SKGJ-MED-008).
Author information
Authors and Affiliations
Contributions
S.B. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design was carried out by S.B. and O.A.A. Acquisition, analysis or interpretation of data was performed by S.B., A.S., O.F., K.S.O'C., O.B.S., F.B., F.K., C.C.F., A.M.D. and O.A.A. Drafting of the manuscript was carried out by S.B., A.S., O.B.S. and O.A.A. Critical revision of the manuscript for important intellectual content was undertaken by S.B., O.B.S., J.I.R., G.H., T.U., S.D., N.E.S. and O.A.A. Statistical analysis was performed by S.B. and A.S. O.A.A. obtained funding and provided administrative, technical and material support. Study supervision was provided by S.B. and O.A.A. All authors approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
O.A.A. has received speaker’s honorarium from Lundbeck and is a consultant to HealthLytix. A.M.D is a founder of and holds equity in CorTechs Labs, Inc. and serves on its Scientific Advisory Board. He is a member of the Scientific Advisory Board of Human Longevity, Inc. and receives funding through research agreements with General Electric Healthcare and Medtronic, Inc. The terms of these arrangements have been reviewed and approved by University of California, San Diego in accordance with its conflict of interest policies. The other authors declare no competing interests.
Additional information
Peer review information Primary handling editor: Stavroula Kousta.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Methods, references and Figs. 1–10.
Supplementary Tables
Supplementary Tables 1–10.
Rights and permissions
About this article
Cite this article
Bahrami, S., Shadrin, A., Frei, O. et al. Genetic loci shared between major depression and intelligence with mixed directions of effect. Nat Hum Behav 5, 795–801 (2021). https://doi.org/10.1038/s41562-020-01031-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41562-020-01031-2
This article is cited by
-
Bidirectional genetic overlap between bipolar disorder and intelligence
BMC Medicine (2022)
-
Polygenic risk and causal inference of psychiatric comorbidity in inflammatory bowel disease among patients with European ancestry
Journal of Translational Medicine (2022)
-
Characterising the shared genetic determinants of bipolar disorder, schizophrenia and risk-taking
Translational Psychiatry (2021)